PREDICTSCRIPT
LIVE

Serial Number

97091070

Owner

Phenomics Health Inc.

Attorney

Roger H. Bora

Filing Date

Oct 25, 2021

Add to watchlist:

No watchlists yet
View on USPTO

PREDICTSCRIPT Trademark

Serial Number: 97091070 • Registration: 7697879

PREDICTSCRIPT is a trademark filed by Phenomics Health Inc. on October 25, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Phenomics Health Inc. (11 trademarks)

60 Yorkshire Drive
Hilton Head Island, SC 29928

Entity Type: 03

Trademark Details

Filing Date

October 25, 2021

Registration Date

February 18, 2025

Published for Opposition

September 19, 2023

Goods & Services

Scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of drug development by others, namely, data-driven analytics and reporting to developers of drugs; scientific and technological services in the field of pharmaceuticals featuring scientific testing, analysis and evaluation of blood samples for the purpose of improving quality in the field of healthcare services, specifically for improving the monitoring and diagnostics of quantitative patient drug exposure, the monitoring and diagnostics of patient drug compliance, data-driven analytics and reporting to providers of healthcare services in the field of pharmacovigilance activities, drug dosage recommendations, initial drug prescribing, and drug switching, all for research purposes and not for medical purposes; genetic testing for scientific research purposes, specifically pharmacogenomic testing, analysis, and evaluation of buccal, saliva and other biological samples for the purposes of analyzing how the genetic makeup of an individual affects their response to drugs, improving drug selection and dosage recommendations, selecting initial and subsequent medications, identifying drug-drug interactions, avoiding adverse drug reactions, developing clinical treatment decision support recommendations, and supporting other medical diagnostic products and prescription drugs; genetic testing for scientific research purposes, namely, analysis of multiple genes and genetic variants and their effect on drug response across multiple therapeutic areas, including but not limited to psychiatry, pain, cardiology, and oncology; scientific and technological services in the field of pharmaceuticals in the nature of scientific testing, analysis and evaluation of biological samples for research purposes, specifically research in the field of clinical trials, and research in the field of new drug development and drug repurposing

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 27, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 27, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 24, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 24, 2025 CRFA
ASSIGNED TO LIE
Jan 24, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 13, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 13, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 15, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 15, 2024 GNRT
SU - NON-FINAL ACTION - WRITTEN
Oct 15, 2024 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jun 15, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 15, 2024 AITU
USE AMENDMENT FILED
May 13, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
May 13, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 11, 2024 EXRA
SOU EXTENSION 1 GRANTED
May 10, 2024 EX1G
SOU EXTENSION 1 FILED
May 10, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
May 10, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 14, 2023 NOAM
EXPARTE APPEAL TERMINATED
Oct 20, 2023 EXPT
EXPARTE APPEAL TERMINATED
Oct 19, 2023 EXPT
EXPARTE APPEAL DISMISSED AS MOOT
Oct 19, 2023 EXDM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 19, 2023 NPUB
PUBLISHED FOR OPPOSITION
Sep 19, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 30, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 15, 2023 CNSA
EX PARTE APPEAL-INSTITUTED
Aug 8, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 8, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Aug 8, 2023 EXAF
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 3, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 3, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 3, 2023 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 27, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 27, 2023 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 10, 2023 GNFN
FINAL REFUSAL E-MAILED
Feb 10, 2023 GNFR
FINAL REFUSAL WRITTEN
Feb 10, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 4, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 4, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 4, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 5, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jul 5, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jul 5, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 15, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 8, 2021 NWOS
NEW APPLICATION ENTERED
Oct 28, 2021 NWAP